The FINANCIAL — Providing safe and effective vaccinations to children, especially as they’ve returned to school, is an important step to protect them from getting sick.…
Read More »
The FINANCIAL — Providing safe and effective vaccinations to children, especially as they’ve returned to school, is an important step to protect them from getting sick.…
You might be interested in
The FINANCIAL — Scientists at Oxford University have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, partly explaining the excess deaths seen in some UK communities, and the impact of COVID-19 in the Indian subcontinent.…
You might be interested in
The FDA and CDC endorsed boosters of the Moderna and Johnson & Johnson COVID-19 vaccines just a month after the agencies did the same for a Pfizer/BioNTech booster. Here’s what’s known today about these shots.…
You might be interested in
The FINANCIAL — The COVID-19 pandemic triggered life expectancy losses not seen since World War II in Western Europe and exceeded those observed around the dissolution of the Eastern Bloc in central and Eastern European countries, according to research published today, led by scientists at Oxford’s Leverhulme Centre for Demographic Science.…
You might be interested in
UGA study identifies link between case severity and infectiousness. Individuals with COVID-19 are most likely to spread the virus to close contacts two days before the onset of symptoms to three days after symptoms appear, and the risk of transmission is highest when patients had mild or moderate disease severity, according to a new study by…
You might be interested in
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant of concern dominant in the UK today, according to a study from the University of Oxford.…
You might be interested in
The FINANCIAL — Scientists are recommending that an autumn ‘booster’ dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern, University of Liverpool notes.…
You might be interested in
The FINANCIAL — A new report launched today by The University of Manchester’s Institute for Collaborative Research on Ageing (MICRA) has revealed the challenged faced during the coronavirus pandemic by people aged 50 and over, especially those living in deprived areas.…
You might be interested in
The FINANCIAL — A new study from researchers at the University of Liverpool shows that decreasing local government funding over recent years probably contributed to declines in life expectancy in some areas of England, which was stalling even prior to the COVID-19 pandemic.…
You might be interested in
Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic disease, with real-world data bearing out that…
You might be interested in
The FINANCIAL — More accurate rapid diagnostics for COVID-19 are being developed using an isothermal test that simultaneously detects two gene targets. The tests are being developed by the i-sense group at University College London (UCL).…
You might be interested in